Analysts’ Weekly Ratings Updates for BXP (BXP)
by Renee Jackson · The Cerbat GemA number of research firms have changed their ratings and price targets for BXP (NYSE: BXP):
- 12/1/2025 – BXP had its price target lowered by analysts at Barclays PLC from $79.00 to $78.00. They now have an “equal weight” rating on the stock.
- 11/25/2025 – BXP had its price target lowered by analysts at Wells Fargo & Company from $77.00 to $74.00. They now have an “overweight” rating on the stock.
- 11/24/2025 – BXP had its “sell (d+)” rating reaffirmed by analysts at Weiss Ratings.
- 11/17/2025 – BXP had its “sell (d+)” rating reaffirmed by analysts at Weiss Ratings.
- 11/14/2025 – BXP had its price target lowered by analysts at Evercore ISI from $77.00 to $76.00. They now have an “in-line” rating on the stock.
- 11/13/2025 – BXP had its price target raised by analysts at Scotiabank from $77.00 to $81.00. They now have a “sector perform” rating on the stock.
- 11/10/2025 – BXP was downgraded by analysts at Weiss Ratings from a “hold (c-)” rating to a “sell (d+)” rating.
- 10/17/2025 – BXP was given a new $77.00 price target on by analysts at The Goldman Sachs Group, Inc.. They now have a “neutral” rating on the stock.
- 10/17/2025 – BXP was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating. They now have a $83.00 price target on the stock.
- 10/13/2025 – BXP was given a new $85.00 price target on by analysts at New Street Research.
- 10/13/2025 – BXP had its price target raised by analysts at Jefferies Financial Group Inc. from $79.00 to $84.00. They now have a “buy” rating on the stock.
- 10/13/2025 – BXP had its price target raised by analysts at Jefferies Financial Group Inc. from $79.00 to $84.00. They now have a “buy” rating on the stock.
- 10/13/2025 – BXP is now covered by analysts at LADENBURG THALM/SH SH. They set a “buy” rating and a $85.00 price target on the stock.
- 10/8/2025 – BXP had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
BXP Cuts Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th were paid a $0.70 dividend. This represents a $2.80 annualized dividend and a dividend yield of 3.9%. The ex-dividend date was Tuesday, September 30th. BXP’s dividend payout ratio (DPR) is -220.47%.
Insider Buying and Selling
In other news, CFO Michael E. Labelle sold 13,422 shares of the company’s stock in a transaction that occurred on Friday, November 7th. The stock was sold at an average price of $72.34, for a total transaction of $970,947.48. Following the completion of the sale, the chief financial officer owned 9,223 shares in the company, valued at $667,191.82. This represents a 59.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Raymond A. Ritchey sold 36,314 shares of BXP stock in a transaction on Monday, December 1st. The shares were sold at an average price of $72.18, for a total transaction of $2,621,144.52. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 70,710 shares of company stock valued at $5,107,771. Company insiders own 1.49% of the company’s stock.
Boston Properties, Inc (NYSE: BXP) (BXP or the Company) is the largest publicly traded developer, owner, and manager of premier workplaces in the United States, concentrated in six dynamic gateway markets – Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, DC. BXP has delivered places that power progress for our clients and communities for more than 50 years.
Further Reading
- Five stocks we like better than BXP
- A Deeper Look at Bid-Ask Spreads
- NVIDIA’s $2B Power Play: Securing the Future of Chip Design
- Canada Bond Market Holiday: How to Invest and Trade
- Insiders Swarm Vertical Aerospace Stock Ahead of Make-or-Break Reveal
- Investing In Preferred Stock vs. Common Stock
- Symbotic Reanimates Market, Long-Term Targets Are Back In Focus